"It’s a major peeve of many medieval historians: the popular belief that people who lived before Christopher Columbus thought that the world was flat."
Doc Daneeka - "I see 2 doomsday possibilities for the slide... [blahblahblah]"
What?! It's obviously because people failed to realise the RNS was just telling us what we've already known since February.
Doc Daneeka - "Does the publication constitute a peer review or not ?"
How could you be invested here for years and not already know that? Yes it's peer reviewed. That's the point of publishing it. If you need confirmation, it's here: "All material is subject to independent peer review."
It consisted of a few people whining that Philip Monk didn't plug the company's name and several others concluding that the statement "it needs government funding" somehow proved that STRIVE was a dead-end. That was literally it.
Oh, and a link to the presentation. Maybe that's what got it deleted.
I'm assuming some holders got bored and saw the opportunity to cut their losses and move elsewhere. I get the impression the pandemic brought in lots of new, inexperienced investors who didn't appreciate how long it takes to make progress in drug development/discovery. So maybe that explains it.
Wigster77 - "It's clear to me that you need to take one for the team and get to 10.01% then Doc :-)"
I only keep pointing out it's a possibility because others here refuse to acknowledge it. In reality I think there's only a very, very slim chance of it.
Manifesto - "Anyone considered that the reason TGF have kept topping up once they were over the crucial 25% was because BP's were sounding them out on their price to agree a TO......."
It's also possible TFG is thinking of putting in a bid without anyone having already approached them.
They might even be able to pick the company up for under 70p/share this spring.